Global Governance for Facilitating Access to Medicines: Role of World Health Organization

Abstract

Growing dissatisfaction with constant interference of trade regime with basic human right to health has necessitated the search for an alternative forum competent to take lead in the struggle for global access to affordable medicines, and thus it ended up with the World Health Organization. The WHO, in turn, recommended a Global Health R&D Treaty. Nevertheless, the clash between global health actors and the industry continues, occasionally affecting the WHO initiatives. Still, there is a room for hope.